Jaekel, N
Lieder, K
Albrecht, S
Leismann, O
Hubert, K
Bug, G
Kröger, N
Platzbecker, U
Stadler, M
de Haas, K
Altamura, S
Muckenthaler, M U
Niederwieser, D
Al-Ali, H K
Article History
Received: 2 April 2015
Revised: 18 July 2015
Accepted: 23 July 2015
First Online: 14 September 2015
Competing interests
: NJ, KH, MS, KdH, SA: None declared. GB: Research funding, travel grants and honoraria, Novartis. NK: Research funding, Novartis. UP: Research funding and honoraria, Novartis. MUM: Consulting fees and payment for the hepcidin analyses, Novartis. DN: Research funding and honoraria, Novartis. HKA-A: Research funding and honoraria, Novartis. KL, SA, OL: Employment, Novartis.